Ladenburg Thalmann Initiates Coverage on Questcor Pharma at Buy, $51 PT
Tickers: QCOR
Ladenburg Thalmann has initiated coverage on Questcor Pharmaceuticals (NASDAQ: QCOR) with a Buy rating and $51 price target.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Tags: Ladenburg Thalmann
Posted in: Price Target, Initiation, Pre-Market Outlook, Analyst Ratings
Partner Network